ADVERTISEMENT

Life Sciences

Device Shortages A Matter Of National Security, Califf Says

During an online seminar hosted by the Alliance for a Stronger FDA, Commissioner Robert Califf discussed key issues facing the agency, including supply chains, device shortages, and the risk of another pandemic.

Sponsored by

Podcast: Challenges in the Development and Manufacturing of ADCs

In this podcast, Andrew Warmington, Manufacturing Editor, Citeline, joins together with industry experts, Simone Secchi, R&D Process Chemist, Olon Group, and Matthieu CULIE, Head of MAB, Pierre Fabre, to discuss the challenges in the development and manufacturing of ADCs.

Mammograms Should Inform Women About Breast Density, FDA Says

The US FDA now requires mammograms include information about breast density, a significant factor that raises breast cancer risk and can hide tumors.

Lab Association Asks Congress To Kill FDA’s Final Rule On LDTs

In a letter to US lawmakers, the Association for Diagnostics and Laboratory Medicine says the FDA’s final rule regulating lab-developed tests will stifle innovation and that Congress needs to step in and stop it.

Pharma Firms To Benefit From New UK Hub-And-Spoke Clinical Trial Network

Pharmaceutical companies will be able to work with a newly-established network of clinical trial delivery centers and primary care providers in all four UK nations as part of a new public-private investment scheme.

NEMA Voices Support For China Tariffs Delay

While the National Electrical Manufacturers Association supports the Biden Administration’s plan to impose tariffs on a range of Chinese goods coming into the US, it also supports holding off on their implantation.

EU Commission Sets Out Plans For New Life Sciences Strategy

As well as planning action to improve the EU’s competitiveness in the life science sector, the European Commission has confirmed that it will propose new legislation to reduce the bloc’s reliance on overseas suppliers of medicines as a way of tackling drug shortages.

UK Government Accentuates Role Of Medtech As It Orders Review Of NHS

One week after winning the UK general election on 4 July, the Labour Party ordered a review of the National Health Service, to be published in September.

Uptake Of Innovation Is UK’s ‘Biggest Hurdle’ In Life Sciences Competitiveness

The latest report on the competitiveness of the UK’s life sciences sector shows that the nation “continues to underperform” on its potential in terms of the adoption of new treatments and innovation, according to industry body the ABPI.

UK Life Sciences Leaders Optimistic After Labour Landslide

However, the country's pharma association says that the new government "needs to hit the ground running and rapidly set out a clear, detailed plan" for what it will do in the coming weeks and years.